Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinoblastoma × Dynamic Contrast Enhanced Magnetic Resonance Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Glioblastoma 4 Astrocytoma 3 Oligodendroglioma 2 Glioma 2 Esophageal Neoplasms 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Optic Nerve Glioma 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Childhood Brain Neoplasm 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Asymptomatic 1 Adenocarcinoma Of Esophagus 1

Interventions

Carboplatin 20 Etoposide 17 Vincristine 14 Filgrastim 11 Melphalan 10 Topotecan 9 Granulocyte Colony-Stimulating Factor 9 Cyclophosphamide 9 Thiotepa 6 Cryotherapy 5 Mesna 4 Busulfan 4 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Ifosfamide 3 Drug Therapy 3 Doxorubicin 3 Watchful Waiting 2 Temozolomide 2 Magnetic Resonance Imaging 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03267459 2026-01-05

PREDIR

Fondation Ophtalmologique Adolphe de Rothschild

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡